|
 |
 |
Élie Besserer-Offroy
Postdoctoral Fellow |
I completed my undergraduate degree
in Medical Biochemistry at Université Claude Bernard -
Lyon I in France. After eight months of internship at
the Institute for Biology and Chemistry of Proteins in
Lyon, I moved in Canada and enrolled in graduate
studies. I started my master’s degree in 2010 in the
Department of Pharmacology of the Université de
Sherbrooke under the supervision of Dr. Sarret and Dr.
Leduc. During my MSc, I was involved in the development
of a BRET-based assay for high throughput screening in
collaboration with Tranzyme Pharma, a biotech company
based in Sherbrooke. In 2012, I started my PhD with Dr.
Sarret as supervisor, and studied the signaling cascades
triggered by new agonists of the neurotensin and apelin
receptors with the aim to discover new and safe
therapeutics for pain management. I finished in 2018 and
joined the lab of Dr. Hébert as a post-doctoral research
fellow funded by the FRQ-S. My research project is to
understand the role played by heterodimers formed of the
apelin receptor and neurotensin receptor 1 or
Kappa-opioid receptor in pain modulation.
